Margaret M. Condron
Papers
1
Total Citations
113
H-Index
1
About
Dr. Margaret M. Condron is a leading biochemist whose research centers on the molecular mechanisms of Alzheimer's disease, with a particular focus on the proteolytic degradation of the amyloid β-protein (Aβ). Her most impactful contribution is the development of innovative fluorescence- and fluorescence polarization-based assays that enable the detailed kinetic analysis of Aβ degradation. This seminal work, published in 2003 and cited over 113 times, addressed a critical methodological gap in the field. Prior to her assays, studying the enzymes that regulate brain Aβ levels—key players in Alzheimer's pathology—was technically challenging and lacked quantitative rigor. By creating robust, practical tools using novel fluorescent substrates, Dr. Condron empowered researchers to systematically investigate the activity of Aβ-degrading proteases, thereby advancing our understanding of how Aβ homeostasis is maintained in health and disrupted in disease. Her work remains a foundational reference for scientists exploring protease-based therapeutic strategies for Alzheimer's disease.
Research Focus
Key Achievements
Top Papers
- 1